These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24215337)
41. Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination. Karhu J; Ala-Kokko TI; Ohtonen P; Syrjälä H Acta Anaesthesiol Scand; 2013 May; 57(5):587-93. PubMed ID: 23379766 [TBL] [Abstract][Full Text] [Related]
42. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073 [TBL] [Abstract][Full Text] [Related]
43. A study of elevated interleukin-8 (CXCL8) and detection of leukocyte migration inhibitory activity in patients allergic to beta-lactam antibiotics. Abe M; Yagi M; Wakasugi Y; Hattori H; Uno K Allergol Int; 2011 Dec; 60(4):497-504. PubMed ID: 21778813 [TBL] [Abstract][Full Text] [Related]
44. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration? Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898 [TBL] [Abstract][Full Text] [Related]
45. Part II. Introduction to the beta-lactam antibiotics. Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105 [No Abstract] [Full Text] [Related]
46. Assessment of a self-designed protocol on patients with adverse reactions to beta-lactam antibiotics. González J; Guerra F; Moreno C; Miguel R; Daza JC; Sánchez Guijo P Allergol Immunopathol (Madr); 1992; 20(5):184-9. PubMed ID: 1292326 [TBL] [Abstract][Full Text] [Related]
47. Work up of patients with history of beta-lactam hypersensitivity. Silva R; Cruz L; Botelho C; Cadinha S; Castro E; Rodrigues J; Castel-Branco MG Allergol Immunopathol (Madr); 2009; 37(4):193-7. PubMed ID: 19775797 [TBL] [Abstract][Full Text] [Related]
48. Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs: A Pragmatic Multicenter Prospective Evaluation. Leis JA; Palmay L; Ho G; Raybardhan S; Gill S; Kan T; Campbell J; Kiss A; McCready JB; Das P; Minnema B; Powis JE; Walker SAN; Ferguson H; Wong B; Weber E Clin Infect Dis; 2017 Oct; 65(7):1059-1065. PubMed ID: 28575226 [TBL] [Abstract][Full Text] [Related]
49. Cutaneous adverse drug reactions seen at a university hospital department of dermatology. Borch JE; Andersen KE; Bindslev-Jensen C Acta Derm Venereol; 2006; 86(6):523-7. PubMed ID: 17106600 [TBL] [Abstract][Full Text] [Related]
50. [Utilization of the knowledge of antibiotic pharmacokinetics in the treatment of thoracic empyema]. Hanke I; Hanslianová M; Kysela P Klin Mikrobiol Infekc Lek; 2007 Jun; 13(3):104-8. PubMed ID: 17703402 [TBL] [Abstract][Full Text] [Related]
51. Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship. George JM; Towne TG; Rodvold KA Pharmacotherapy; 2012 Aug; 32(8):707-21. PubMed ID: 23307519 [TBL] [Abstract][Full Text] [Related]
52. Collaboration between allergists and pharmacists increases β-lactam antibiotic prescriptions in patients with a history of penicillin allergy. Park MA; McClimon BJ; Ferguson B; Markus PJ; Odell L; Swanson A; Kloos-Olson KE; Bjerke PF; Li JT Int Arch Allergy Immunol; 2011; 154(1):57-62. PubMed ID: 20664278 [TBL] [Abstract][Full Text] [Related]
54. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units. Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152 [TBL] [Abstract][Full Text] [Related]
55. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. McFarland LV; Surawicz CM; Greenberg RN; Elmer GW; Moyer KA; Melcher SA; Bowen KE; Cox JL Am J Gastroenterol; 1995 Mar; 90(3):439-48. PubMed ID: 7872284 [TBL] [Abstract][Full Text] [Related]
56. Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Singh N; Yu VL; Mieles LA; Wagener MM Am J Med; 1993 Mar; 94(3):251-6. PubMed ID: 8452148 [TBL] [Abstract][Full Text] [Related]
57. Third-generation beta-lactam antibiotics for treatment of orthopedic infections. Mogabgab WJ; Haddad RJ; Longenecker SL; Buchanan TC; Johnston R; Macey TI; Bernard T; Floyd I Clin Ther; 1982; 5(1):21-43. PubMed ID: 7127366 [TBL] [Abstract][Full Text] [Related]
58. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre. Shalviri G; Yousefian S; Gholami K J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488 [TBL] [Abstract][Full Text] [Related]
59. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. Falagas ME; Matthaiou DK; Bliziotis IA J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057 [TBL] [Abstract][Full Text] [Related]
60. [Studies on the pathogenic mechanism of beta-lactam hypersensitivity by the detection of leucocyte migration activating factor and leucocyte migration inhibitory factor--structural correlations with allergic symptoms due to beta-lactam antibiotics]. Uno K Arerugi; 1992 Mar; 41(3):418-27. PubMed ID: 1575639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]